iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on June 1, 2023
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global…
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global…
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global…
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
PURCHASE, N.Y., May 23, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company”…
PURCHASE, N.Y., May 23, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company”…
Potent and durable target engagement observed across cohorts, including with 10 mg doses administered every…
Potent and durable target engagement observed across cohorts, including with 10 mg doses administered every…
Preclinical data establish MRT-6160’s ability to potently and selectively degrade VAV1 and inhibit disease progression…
Preclinical data establish MRT-6160’s ability to potently and selectively degrade VAV1 and inhibit disease progression…
CTS Activities will Focus on Analytic Method Transfer, Manufacturing of R&D Engineering Batches, and Stability…
CTS Activities will Focus on Analytic Method Transfer, Manufacturing of R&D Engineering Batches, and Stability…
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Apnimed, a clinical-stage pharmaceutical company focused on…
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Apnimed, a clinical-stage pharmaceutical company focused on…
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and…
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and…
Recent upgrades lead to testing results that show customers have the best experience on the…
Recent upgrades lead to testing results that show customers have the best experience on the…